| DWS CONCEPT NISSAY JAPAN VALUE EQUITY JPY LC | RVI JAPÓN VALOR | 29,66% | · | · | · |
| LO FUNDS - TARGETNETZERO EMERGING MARKETS EQUITY (CHF) I CAP | RVI CHINA | 29,66% | · | · | · |
| ROBECO QI EMERGING CONSERVATIVE EQUITIES F EUR | RVI EMERGENTES | 29,66% | 62,27% | 69,74% | 116,83% |
| CANDRIAM EQUITIES L BIOTECHNOLOGY I CAP USD | RVI BIOTECNOLOGÍA | 29,65% | 68,87% | 70,67% | 199,12% |
| CT (LUX) RESPONSIBLE GLOBAL EMERGING MARKETS EQUITY R USD ACC | RVI EMERGENTES | 29,65% | 62,54% | 36,67% | 102,13% |
| JANUS HENDERSON HF - JAPANESE SMALLER COMPANIES X2 USD | RVI JAPÓN SMALL/MID CAP | 29,65% | 47,11% | 36,28% | 87,49% |
| NOMURA FUNDS IRELAND - JAPAN SMALL CAP EQUITY FUND F JPY | RVI JAPÓN SMALL/MID CAP | 29,65% | 65,87% | 72,26% | · |
| T.ROWE JAPANESE EQUITY FUND Q (USD) | RVI JAPÓN | 29,65% | 66,28% | 17,31% | · |
| JPM THEMATICS-GENETIC THERAPIES C (ACC) USD | RVI BIOTECNOLOGÍA | 29,64% | 37,47% | -13,81% | · |
| UBS (LUX) EQUITY SICAV - GLOBAL EMERGING MARKETS OPPORTUNITY (USD) Q-ACC | RVI EMERGENTES CRECIMIENTO | 29,64% | 74,21% | 34,00% | · |
